Detalhe da pesquisa
1.
Outcomes of Patients with Child-Pugh B and Unresectable Hepatocellular Carcinoma Undergoing First-Line Systemic Treatment with Sorafenib, Lenvatinib, or Atezolizumab Plus Bevacizumab.
Oncology
; 102(3): 239-251, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-37729889
2.
Serum PreS1 and HBsAg ratio reflects liver fibrosis and predicts the development of hepatocellular carcinoma in chronic hepatitis B patients.
J Viral Hepat
; 28(9): 1304-1311, 2021 09.
Artigo
Inglês
| MEDLINE | ID: mdl-34105859
3.
Abatacept treatment for patients with severe acute hepatitis caused by hepatitis B virus infection-Pilot study.
J Viral Hepat
; 28(2): 400-409, 2021 02.
Artigo
Inglês
| MEDLINE | ID: mdl-33197288
4.
Efficacy and Safety of Lenvatinib-Transcatheter Arterial Chemoembolization Sequential Therapy for Patients with Intermediate-Stage Hepatocellular Carcinoma.
Oncology
; 99(8): 507-517, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-33946070
5.
Comparison of the Clinical Outcome of Ramucirumab for Unresectable Hepatocellular Carcinoma with That of Prior Tyrosine Kinase Inhibitor Therapy.
Oncology
; 99(5): 327-335, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-33677453
6.
Clinical Outcomes of 2nd- and 3rd-Line Regorafenib for Advanced Hepatocellular Carcinoma.
Oncology
; 99(8): 491-498, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34000725
7.
Increasing incidence of non-HBV- and non-HCV-related hepatocellular carcinoma: single-institution 20-year study.
BMC Gastroenterol
; 21(1): 306, 2021 Jul 31.
Artigo
Inglês
| MEDLINE | ID: mdl-34332532
8.
Extracellular water to total body water ratio obtained by bioelectrical impedance analysis determines the dose intensity of lenvatinib for the treatment of patients with advanced hepatocellular carcinoma.
J Gastroenterol Hepatol
; 36(6): 1685-1693, 2021 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-33326154
9.
Trends in Hepatic Functional Reserve of Patients with Hepatocellular Carcinoma Treated with Tyrosine Kinase Inhibitors.
Oncology
; 98(10): 727-733, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-32712613
10.
Analysis of Post-Progression Survival in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib.
Oncology
; 98(11): 787-797, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-32882687
11.
Impact of viral eradication by direct-acting antivirals on the risk of hepatocellular carcinoma development, prognosis, and portal hypertension in hepatitis C virus-related compensated cirrhosis patients.
Hepatol Res
; 50(11): 1222-1233, 2020 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-32767446
12.
Incidence of microsatellite instability-high hepatocellular carcinoma among Japanese patients and response to pembrolizumab.
Hepatol Res
; 50(7): 885-888, 2020 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-32088930
13.
Real-world efficacy of sofosbuvir plus velpatasvir therapy for patients with hepatitis C virus-related decompensated cirrhosis.
Hepatol Res
; 50(11): 1234-1243, 2020 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-32914512
14.
Risk factors for histological progression of non-alcoholic steatohepatitis analyzed from repeated biopsy cases.
J Gastroenterol Hepatol
; 35(8): 1412-1419, 2020 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-31896166
15.
The impact of interferon-free direct-acting antivirals on clinical outcome after curative treatment for hepatitis C virus-associated hepatocellular carcinoma: Comparison with interferon-based therapy.
J Med Virol
; 91(4): 650-658, 2019 04.
Artigo
Inglês
| MEDLINE | ID: mdl-30381831
16.
Correlation between Early Tumor Marker Response and Imaging Response in Patients with Advanced Hepatocellular Carcinoma Treated with Lenvatinib.
Oncology
; 97(2): 75-81, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-31242488
17.
Pruritus in patients with chronic liver disease and serum autotaxin levels in patients with primary biliary cholangitis.
BMC Gastroenterol
; 19(1): 169, 2019 Oct 24.
Artigo
Inglês
| MEDLINE | ID: mdl-31651244
18.
Advanced liver fibrosis effects on the response to sofosbuvir-based antiviral therapies for chronic hepatitis C.
J Med Virol
; 90(12): 1834-1840, 2018 12.
Artigo
Inglês
| MEDLINE | ID: mdl-30016555
19.
Comparison of Outcome of Hepatic Arterial Infusion Chemotherapy Combined with Radiotherapy and Sorafenib for Advanced Hepatocellular Carcinoma Patients with Major Portal Vein Tumor Thrombosis.
Oncology
; 94(4): 215-222, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-29428943
20.
Hepatic arterial infusion chemotherapy followed by sorafenib in patients with advanced hepatocellular carcinoma (HICS 55): an open label, non-comparative, phase II trial.
BMC Cancer
; 18(1): 633, 2018 Jun 04.
Artigo
Inglês
| MEDLINE | ID: mdl-29866075